Umemura S. Involvement of Runx3 in the basal transcriptional activation of the mouse angiotensin II type 1 receptor-associated protein gene. Physiol Genomics 43: 884 -894, 2011. First published May 17, 2011 doi:10.1152/physiolgenomics.00005.2011.-We previously cloned a molecule that interacts with angiotensin II type 1 (AT1) receptor to exert an inhibitory function on AT1 receptor signaling that we named ATRAP/Agtrap (for AT1 receptor-associated protein). In the present study we examined the regulation of basal ATRAP gene expression using renal distal convoluted tubule cells. We found that serum starvation upregulated basal expression of ATRAP gene, a response that required de novo mRNA and protein synthesis. Luciferase assay revealed that the proximal promoter region directs transcription and that a putative binding site of runt-related transcription factors (RBE) is important for transcriptional activation. The results of RBE-decoy transfection and endogenous knockdown by small interference RNA showed that the runt-related transcription factor Runx3 is involved in ATRAP gene expression. Chromatin immunoprecipitation assay also supported the binding of Runx3 to the ATRAP promoter in renal distal convoluted tubule cells. Immunohistochemistry demonstrated the expression of Runx3 and ATRAP proteins in the distal convoluted and connecting tubules of the kidney in consecutive sections. Furthermore, the Runx3 immunostaining was decreased together with a concomitant suppression of ATRAP expression in the affected kidney after 7 days of unilateral ureteral obstruction. These findings indicate that Runx3 plays a role in ATRAP gene expression in renal distal tubular cells both in vitro and in vivo. distal tubule; gene transcription; renin-angiotensin system; transcription regulation ACTIVATION OF THE angiotensin II (ANG II) type 1 (AT1) receptor at local sites is involved in the pathogenesis of hypertension and the ensuing related target organ damages, as well as the development of renal inflammatory and fibrotic disease. We previously performed a yeast twohybrid system screening of a murine kidney cDNA library and identified the molecule AT1 receptor-associated protein (ATRAP/Agtrap), which interacts specifically with the COOH-terminal cytoplasmic domain of the AT1 receptor (6, 17, 26) . Previous in vitro studies using cardiovascular cells suggested that ATRAP promotes AT1 receptor internalization and modulates the signaling pathways of the AT1 receptor (1, 10, 19, 28) .
distal tubule; gene transcription; renin-angiotensin system; transcription regulation ACTIVATION OF THE angiotensin II (ANG II) type 1 (AT1) receptor at local sites is involved in the pathogenesis of hypertension and the ensuing related target organ damages, as well as the development of renal inflammatory and fibrotic disease. We previously performed a yeast twohybrid system screening of a murine kidney cDNA library and identified the molecule AT1 receptor-associated protein (ATRAP/Agtrap), which interacts specifically with the COOH-terminal cytoplasmic domain of the AT1 receptor (6, 17, 26) . Previous in vitro studies using cardiovascular cells suggested that ATRAP promotes AT1 receptor internalization and modulates the signaling pathways of the AT1 receptor (1, 10, 19, 28) .
With respect to the tissue distribution and regulation of ATRAP expression in vivo, the ATRAP mRNA and protein are abundantly and widely distributed along the renal tubules, including the distal and proximal tubules (18, 29) . We also demonstrated that there is a tissue-specific regulatory balancing of the expression of ATRAP and the AT1 receptor during the development of hypertension in rats (25) . The activation of tissue ATRAP in transgenic models in which ATRAP expression was increased beyond baseline promoted ANG II-mediated internalization of the AT1 receptor (33) and abolished cardiac hypertrophy in response to ANG II stimulation (34) . A recent study showed that a genetic deficiency of ATRAP in mice caused an enhanced surface expression of AT1 receptor in the kidney and an elevation of blood pressure through volume expansion (21) . Therefore, it is important to elucidate the molecular mechanism of the tissue-specific regulation of ATRAP gene expression to determine the regulatory machinery for the tissue ATRAP level and/or ATRAP activity under both physiological and pathological conditions. Thus, as a first step, in this study we examined the basal transcriptional regulation of the ATRAP gene using mouse distal convoluted tubule cells (mDCT cells). These cells have been shown to have the phenotype of a polarized tight junction epithelium with morphologic and functional features retained from the parental cells (8, 22) . The mDCT cells also express the endogenous AT1 receptor and ATRAP genes, as shown by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblot analysis (18) .
In the present study, we found that serum starvation upregulates basal ATRAP gene expression in renal DCT cells and that Runx3, one of the Runt-related transcription factors, is involved in the transcriptional activation of ATRAP gene expression. The Runt-related transcription factors have a conserved 128-amino acid Runt domain, a name derived from its homology to the pair-rule related gene "runt," which plays a role in the segmented body patterning of Drosophila (5) . The Runt-related transcription factors consist of Runx1, Runx2, and Runx3, and all three Runx proteins bind to the common DNA motif TGPyGGTPy (Py is a pyrimidine), and each of these heterodimerizes with CBF␤, which makes no direct contact with DNA but, rather, increases DNA binding to Runx proteins.
MATERIALS AND METHODS
This study was performed in accordance with the National Institutes of Health guidelines for the use of experimental animals. All of the animal studies were reviewed and approved by the Animal Studies Committee of Yokohama City University.
Cell culture. The mDCT cells were kindly provided by Dr. Peter A. Friedman (University of Pittsburgh School of Medicine, Pittsburgh, PA). The cells had been previously isolated and functionally characterized as described (9, 22) .
Animals and treatment. Adult C57BL/6 mice were purchased from Oriental Yeast Kogyo (Tokyo, Japan). The procedure of unilateral ureteral obstruction (UUO) was performed using C57BL/6 mice as described previously (23) . Briefly, with the mice under anesthesia, the left ureter was ligated at two locations. Mice that were operated on were killed under anesthesia 7 days after UUO. Sham operation was also performed, in which the ureters were manipulated but not ligated.
Immunoblot analysis. Characterization and specificity of the anti-mouse ATRAP antibody have been described (23, 28, 29) . The total membrane fraction was isolated using a Plasma Membrane Protein Extraction Kit (BioVision) according to the manufacturer's protocol. Immunoblot analysis was performed as described previously (23, 28, 29, 31, 34) , and the images were analyzed quantitatively using a FUJI LAS3000 Image Analyzer (FUJI Film, Tokyo, Japan) for determination of the ATRAP protein levels.
Plasmid construction and transcriptional ATRAP promoter assay. The KpnI/BamHI fragment of the 374-bp mouse ATRAP promoter (Ϫ302 to ϩ72 of the putative transcriptional start site) was amplified from C57BL/6J genomic DNA using the pair of primers in Table 1 . Construction of mutations in the Runx-binding element (RBE) and SMAD-binding element (SBE) was performed by oligonucleotide (ODN)-directed mutagenesis (11, 13, 27) . The sequences of the ODN used to create the mutated SBE (SBE-mt) and mutated RBE (RBE-mt) are shown in Table 1 . To normalize transfection efficiency, we employed the Dual-Luciferase Assay System (Promega) as described previously (22) .
Transfection of decoy ODN and small interfering RNA. The sequences of the decoy ODN against RBE and control HA ODN are Table 1 . Primer sequences used in the study
Primers
Primer Sequences
Construction of wild-type and mutated ATRAP promoter-containing plasmids
Wild-type ATRAP promoter forward 5=-ggggtacCTTGTGCAAGGGAAGTAAGA-3= reverse 5=-cgggatccGAACTCGGGAACAAACTTCCT-3= SBE-mt forward 5=-AGAGAGGATGTTCTGGGCCTCCACCAACTGTTACCACACCCGCAG-3= reverse 5=-CTGCGGGTGTGGTAACAGTTGGTGGAGGCCCAGAACATCCTCTCT-3= RBE-mt forward 5=-TGGGCAGACACCAACTGTTAGTGTACCCGCAGTTTCTGCCCGCTT-3= reverse 5=-AAGCGGGCAGAAACTGCGGGTACACTAACAGTTGGTGTCTGCCCA-3=
Transfection of decoy ODN
RBE-decoy ODN 5=-CTCGTCTACCACATGCACCGT-3= and 5=-ACGGTGCATGTGGTAGACGAG-3= HA-decoy ODN 5=-CCATACGATGTTCCAGATTAC-3= and 5=-GGTATGCTACAAGGTCTAATG-3=
Transfection of siRNA siRunx1 sense 5=-ccgucuuuacaaauccgccTT-3= antisense 5=-ggcggauuuguaaagacggTG-3= siRunx2 sense 5=-cgaauggcagcacgcuauuAA-3= antisense 5=-aauagcgugcugccauucgAG-3= siRunx3 sense 5=-uucaacgaccuucgauucgTG-3= antisense 5=-cgaaucgaaggucguugaaCC-3= siHA sense 5=-ccauacgauguuccagauuAC-3= antisense 5=-aaucuggaacaucguauggGT-3=
Real-time RT-PCR analysis
Runx1 forward 5=-TAGCGAGATTCAACGACCTC-3= reverse 5=-GTGGCGGATTTGTAAAGACG-3= Runx2 forward 5=-GTACTTCGTCAGCATCCTAT-3= reverse 5=-AGCGTGCTGCCATTCGAGGT-3= Runx3 forward 5=-GGTTCAACGACCTTCGATTC-3= reverse 5=-GGTTGGTGAACACGGTGATT-3= shown in Table 1 . To knockdown the endogenous expression of Runx proteins with small interfering RNA (siRNA), siRunx1, siRunx2, and siRunx3 primers were synthesized ( Table 1) . As a negative control, siHA primers were also synthesized. The annealed double-strand decoy ODN (100 nM) or siRNA (2.5-10 nM) was introduced into mDCT cells using Lipofectamine RNAiMAX (Invitrogen).
Real-time quantitative RT-PCR analysis.
Total RNA was extracted and purified using the RNeasy Kit (QIAGEN), and real-time quantitative RT-PCR analysis was performed as described previously (34) . The detection primer sequences for Runx1, Runx2, and Runx3 are shown in Table 1 .
Co-immunoprecipitation. Kidneys were minced, homogenized in reaction buffer (20 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM DTT, and protease inhibitors), and centrifuged at 3,000 g for 30 min. Then, the solubilized proteins were subjected to absorption by protein G-beads to avoid a nonspecific reaction. For immunoprecipitation, anti-PY antibody (clone 6B4, MBL) cross-linked protein G-beads with Bis (sulfosuccinimidyl) suberate (#21580 Thermo Fisher Scientific) were used. Immunoblotting was performed using anti-Runx3 antibody (AV37263, Sigma-Aldrich).
Chromatin immunoprecipitation assay. Chromatin immunoprecipitation (ChIP) assay with anti-Runx3 antibody or normal rabbit IgG was performed using the detection primers in Table 1 , essentially according to the manufacturer's protocol (Active Motif) (2, 15) . Briefly, mDCT cells transiently transfected with the wild-type or mutated ATRAP promoter-containing plasmids were treated with paraformaldehyde to cross-link the protein-DNA complexes. Then, cell lysates were sonicated to reduce the DNA fragments to an average size of ϳ500 bp. Following immunoprecipitation with anti-Runx3 antibody or normal rabbit IgG as control, DNA was purified from the antibody-bound and unbound fractions, and enrichment of the ATRAP promoter sequences in the bound fraction was assayed by the overlap extension PCR method (13) .
Immunohistochemistry. Immunohistochemistry was performed essentially as described previously (23, 29) . The sections were incubated with anti-RUNX3 antibody (H-50, sc-30197; Santa Cruz Biotechnology, Santa Cruz, CA) diluted at 1:50. For the study of specific nephron markers, the sections were incubated with 1) aquaporin 2 antibody (#178612, Calbiochem), 2) calbindin D-28K antibody (C2724, Sigma-Aldrich), or 3) Tamm-Horsfall glycoprotein antibody (sc-20631, Santa Cruz Biotechnology).
Statistical analysis. Data are expressed as the means Ϯ SD. Statistical significance was determined using unpaired Student's t-test or analysis of variance followed by Bonferroni test, with P Ͻ 0.05 considered statistically significant.
RESULTS

Serum deprivation-mediated regulation of ATRAP expression involves the activation of transcription and translation in mDCT cells.
To examine whether external stimuli exert an influence on the expression of the ATRAP gene in mDCT cells, we first assessed the effects of various vasoactive substances by immunoblot analysis, such as ANG II and aldosterone, on ATRAP protein expression. After mDCT cells were incubated with serum-free medium for 24 h, mDCT cells were incubated with the indicated medium for an additional 24 h. Although treatment with ANG II (1 M) or aldosterone (1 M) did not significantly affect ATRAP protein expression, the expression was markedly decreased after exposure of the cells to 5% serum (Fig. 1A) . This inhibitory effect of serum on basal ATRAP expression was not affected by costimulation with ANG II (Fig. 1B) . These results show that serum is a dominant inhibitor of ATRAP gene expression in mDCT cells.
To determine whether serum starvation increased ATRAP gene expression, we examined the time course of ATRAP protein expression in mDCT cells treated with various concentrations of serum. Expression of the ATRAP protein started to increase 3 h after treatment with 0 or 1.0% serum and peaked at 6 h, and at 24 h the level was still elevated compared with baseline, while treatment with 2.5 or 5% serum did not affect ATRAP protein expression (Fig. 1C) . The results of real-time quantitative RT-PCR analysis showed that the serum starvation-induced increase in ATRAP protein expression was accompanied by an activation of ATRAP mRNA expression (Fig. 1D) , indicating transcription plays a role in the basal expression of the ATRAP gene.
ATRAP is predicted to have three transmembrane domains (6, 17), so we also examined the effect of serum starvation on basal ATRAP protein expression using the total cellular membrane fraction. The results showed that serum starvation increased the basal ATRAP protein expression in the membrane Fig. 2 . The Runx binding element (RBE) and SMAD binding element (SBE) are important for transcriptional activation of the ATRAP promoter in mDCT cells. A: sequences of the SBE and RBE in the proximal promoter regions of the human, rat, and mouse ATRAP genes. B: construction of site-directed mutations in the SBE and RBE in the mouse ATRAP promoter sequence. Wild-type sequences (wt.) and mutated sequences (mt.) are shown. Effects of mutations in the SBE and RBE on the transcriptional activity of the mouse ATRAP promoter (Ϫ302 to ϩ72 of the transcriptional start site)-luciferase hybrid gene in serum containing (C, 5% serum) or deprived (D, 0% serum) mDCT cells. The relative luciferase activities were calculated relative to those achieved with the promoterless control plasmid (n ϭ 3). **P Ͻ 0.01, vs. wild-type sequences. fraction as well (Fig. 1E) , and membrane fraction extracts were used for the analysis of ATRAP protein expression thereafter. Next, to determine whether de novo RNA or protein synthesis was required for the starvation-induced increase in basal ATRAP expression, mDCT cells were treated with actinomycin D or cycloheximide and incubated for 6 h in the presence or absence of 5% serum. The RNA synthesis inhibitor actinomycin D (Fig. 1F) , as well as the protein synthesis inhibitor cycloheximide (Fig. 1G) , significantly suppressed the starvation-mediated increase in basal ATRAP protein expression. These results demonstrate that both de novo mRNA transcription and de novo protein synthesis are required for the upregulation of basal ATRAP expression by serum starvation.
The Analysis of the proximal promoter region made up of approximately Ϫ300 bp of the putative transcriptional start site of the ATRAP gene, with the MOTIF Search program (http:// motif.genome.jp/), showed the presence of a putative SBE and Runx binding site (RBE), which are highly conserved among the mouse, rat, and human forms ( Fig. 2A) . To examine the functional role of these conserved elements in the regulation of ATRAP gene transcription, we mutated the core binding sequences of SBE and RBE in the endogenous mouse ATRAP promoter by PCR-directed mutagenesis (Fig. 2B) . Although the proximal promoter region from Ϫ302 to ϩ72 of the putative transcriptional start site of the ATRAP gene exhibited substantial transcriptional activity, site-directed mutations of either SBE or Fig. 3 . RBE decoy decreases endogenous ATRAP gene expression in mDCT cells. A: quantitative real-time RT-PCR analysis showing the effects of RBE-decoy transfection on the relative mRNA levels of Runx1, Runx2, Runx3, and ATRAP. RNA quantity was normalized to the signal generated by the constitutively expressed 18S ribosomal RNA and expressed relative to extracts derived from nondeprived mDCT cells transfected with control hemagglutinin (HA) decoy (5% serum ϩ, HAdecoy ϩ) (n ϭ 3). *P Ͻ 0.05, vs. HA, hemagglutinin; decoy; **P Ͻ 0.01, vs. HA decoy. B: immunoblot showing the effects of RBE-decoy transfection on ATRAP protein expression in the total membrane fraction of the serum deprived (0% serum) or nondeprived (5% serum) mDCT cells (n ϭ 3). HA decoy was used as a control. Immunodetection membrane stained by Coomassie blue dye served as an internal control for the determination of equal protein loading. **P Ͻ 0.01, vs. HA decoy.
RBE significantly decreased the transcriptional activity in serum containing (Fig. 2C) or deprived (Fig. 2D ) mDCT cells.
Runx3 is involved in the upregulation of endogenous ATRAP gene expression in mDCT cells.
To inhibit the binding of the runt-related transcription factors (Runx1, Runx2, and Runx3) to RBE, we performed transient transfection studies using a decoy ODN method that has been well described (7, 20) . A double-stranded decoy ODN was transfected into mDCT cell cultures to interfere with Runx binding to RBE, and the effects on the endogenous expression of Runx and ATRAP were subsequently analyzed. The results of real-time quantitative RT-PCR analysis showed that the ATRAP mRNA level had a tendency of decrease as the result of RBE-decoy transfection despite there being no apparent change in the expression of Runx mRNA (Fig. 3A) . Interestingly, serum starvation upregulated Runx3 mRNA levels, and this upregulation was not affected by RBE-decoy transfection (Fig. 3A) . Furthermore, transfection with the RBE-decoy ODN decreased the serum starvation-induced upregulation of the ATRAP protein levels in mDCT cells (Fig. 3B) . These results indicate that Runx binding sites are involved in the transcriptional activation of ATRAP gene by serum starvation in mDCT cells.
To further determine which Runx protein is responsible for the serum starvation-induced activation of ATRAP expression , and Runx3 (C) mRNA levels. RNA quantity was normalized to the signal generated by constitutively expressed GAPDH and is expressed relative to those achieved with extracts derived from mDCT cells transfected with control siHA (n ϭ 3). **P Ͻ 0.01, vs. siHA. D: quantitative real-time RT-PCR analysis showing the effects of respective siRNA transfection on the relative ATRAP mRNA level. RNA quantity was normalized to the signal generated by constitutively expressed GAPDH and expressed relative to those achieved with extracts derived from mDCT cells transfected with control siHA (n ϭ 3). **P Ͻ 0.01, vs. siHA. E: immunoblot showing the effects of respective siRNA transfection on ATRAP protein expression in the total membrane fraction of the deprived (0% serum) mDCT cells (n ϭ 3). siHA was used as a control. **P Ͻ 0.01, vs. siHA transfected into the deprived mDCT cells. F: immunoblot showing the effects of respective siRNA transfection on ATRAP protein expression in the total membrane fraction of the serum containing (5% serum) or deprived (0% serum) mDCT cells (n ϭ 3). siHA was used as a control. *P Ͻ 0.05, vs. siHA. Immunodetection of the membrane stained by Coomassie blue dye served as an internal control for the determination of equal protein loading.
in mDCT cells, we examined the effect of Runx siRNA transfection on endogenous ATRAP gene expression. The mRNA levels of Runx1 (Fig. 4A), Runx2 (Fig. 4B) , and Runx3 (Fig. 4C) were significantly decreased after transfection with their respective siRNA in serum-starved mDCT cells. Importantly, among these Runx siRNAs, only the siRNA reduction of Runx3 resulted in a significant decrease in the levels of ATRAP mRNA (Fig. 4D) . Furthermore, Runx3 knockdown caused a significant The relative values of enrichment were calculated relative to the input DNA (n ϭ 3). Normal IgG was used as a control. *P Ͻ 0.05, vs. normal IgG. C: schematic explanation of the overlap extension PCR detection in the ChIP assay. Briefly, mDCT cells transiently transfected with the wild-type or mutated ATRAP promoter-containing plasmids were treated with paraformaldehyde to cross-link the protein-DNA complexes. Cell lysates were sonicated to reduce the DNA fragments to an average size of ϳ500 bp. Following immunoprecipitation with anti-Runx3 antibody or normal rabbit IgG, DNA was purified from the antibody-bound and unbound fractions, and the enrichment of the ATRAP promoter fragment in the bound fraction was assayed by the overlap extension PCR method. The overlap extension PCR analysis was performed using the forward primer (Ϫ390), which anneals to genomic DNA, and the reverse primer (Ϫ246), which anneals to both genomic and plasmid DNA. DNA, and the reverse primer (Ϫ246), which anneals to both genomic and plasmid DNAs. The ChIP assay results support a direct interaction of Runx3 with the ATRAP promoter in mDCT cells. Notably, since mutations of either SBE or RBE significantly decreased the occupancy of the ATRAP promoter by Runx3, neither Runx3 nor SMAD by itself is sufficient, and a combinatorial interaction of Runx3 and SMAD appears to be necessary for the efficient binding of Runx3 to the ATRAP promoter.
Runx3 is expressed mainly in the DCT and CNT in the mouse kidney. While we previously demonstrated that ATRAP is highly expressed in the mouse kidney (29) and other studies have shown that Runx3 is abundantly expressed in epithelial cells of the gastrointestinal tract (4, 14) , there is no report of Runx3 expression in the mouse kidney. Thus, we examined endogenous Runx3 protein expression in the kidney of adult C57BL/6J mice. The Runx proteins share a common COOH-terminal PY-motif, and immunoprecipitation using an anti-PY motif antibody and the mouse kidney extracts followed by immunoblot analysis revealed that the antiRunx3-specific antibody recognized an apparent molecular mass of ϳ44 kDa, which was consistent with the predicted molecular mass (Fig. 6A) .
We then examined Runx3 protein distribution in normal adult mouse kidneys sections by immunohistochemistry. We found the Runx3 immunostaining sites to be localized to renal tubules in the cortex, with no involvement of the medulla or papilla (data not shown). To identify the specific tubular segments in the Runx3 immunostaining, consecutive sections were stained for Runx3 and markers specific to the tubular segments (Fig. 6B) . We used a specific antibody against calbindin-D, a calcium-binding protein that is expressed primarily in the DCT and connecting tubules (CNT) (16, 30) , and Runx3 protein immunoreactivity was observed specifically in the calbindin-D positive distal tubules (DCT and CNT) other than the macula densa (Fig. 6C, calbindinD28K and Runx3). We also used a polyclonal antibody against the Tamm-Horsfall protein that is expressed in the thick ascending limbs of the loop of Henle, and a polyclonal antibody against aquaporin 2, which is specifically expressed in the collecting tubules. Runx3 immunostaining was not detected in the Tamm-Horsfall protein-positive tubules (Fig. 6C, Runx3 and THP/uromodulin, arrow) and was detected only weakly in the early portion of the distal tubules, which were positive for both calbindin-D and Tamm-Horsfall protein (Fig. 6C, calbindinD28K , Runx3, and THP/uromodulin, arrowhead). Runx3 immunostaining was largely absent in the aquaporin 2-positive tubules (Fig. 6D, AQP2 and Runx3, arrow) and when evident was only partially observed (Fig. 6D,  AQP2 and Runx3, arrowhead). There was no significant Runx3 staining in the glomeruli, proximal tubules, collecting ducts, or vasculature including the arcuate artery, interlobular arteries, and arterioles (data not shown).
We investigated whether ATRAP and Runx3 are coexpressed in the same tubular segment. In consecutive sections stained for ATRAP and Runx3, all of the Runx3-immunopositive distal tubules expressed ATRAP (Fig. 6E , ATRAP and Runx3, arrowhead), indicating partial coexpression of Runx3 with ATRAP in the distal tubules (DCT and CNT) of the mouse kidney. With respect to the intracellular distribution of Runx3 in the distal tubular cells (DCT and CNT), the staining of Runx3 was intense in the perinuclear and cytosolic region on the apical side at higher magnification (Fig. 6E, Runx3) . Finally, we examined the effects of UUO on Runx3 and ATRAP expression. ATRAP mRNA expression was significantly downregulated in the affected kidney after 7 days of UUO, with a concomitant decrease in ATRAP immunostaining (Fig. 7, A and B) . On the other hand, while the Runx3 mRNA expression was upregulated in the affected kidney after 7 days of UUO, the distal tubules were not immunopositive for Runx3 (Fig. 7, A and B) .
DISCUSSION
Serum starvation in this study was found to be a major positive regulator of ATRAP gene expression in mDCT cells. Serum starvation is known to reduce cellular proliferation and induce differentiation in cultured cells, including renal tubule cells (3) , and this may include increased ATRAP expression in mDCT cells. Since the starvation-induced increase in basal ATRAP expression was inhibited by treatment with either actinomycin D or cycloheximide (Fig. 1, F and G) , it is likely that the serum starvation induced activation of basal ATRAP expression involves de novo mRNA and protein synthesis. Sequence analysis of the 5=-flanking region of the ATRAP gene using the TF Search program and Signal Scan algorithm revealed the absence of a TATA box and the presence of a GC-rich region extending Ͼ200 nt from the initiating methionine. The percentage of GC dinucleotides in this region ranged between 65 and 80%, with a CG:GC ratio of 0.94, thus fulfilling the length and base composition criteria for a canonical CpG island specifically located at the transcriptional start site (32) .
The results of the transient transfection assay demonstrate that the proximal promoter region from Ϫ302 to ϩ72 of the ATRAP gene is sufficient to drive luciferase reporter gene expression in deprived mDCT cells. Mutation of either SBE or RBE significantly decreased the promoter activity of the ATRAP gene, but a mutation of both SBE and RBE did not further decrease the promoter activity in the transfection assay (Fig. 2) . Similarly, mutations of SBE or RBE alone or together significantly decreased the binding of Runx3 to the ATRAP promoter to a similar extent in the ChIP assay (Fig. 5) . These results suggest that the combinatorial interaction of SBE and RBE is important for the binding of Runx3 to the ATRAP promoter and transcriptional activation of the proximal promoter of the ATRAP gene by Runx3. This is consistent with previous studies showing that the intranuclear targeting of the Runx-Smad complex to transcriptionally active SBE and RBE adjacent sites is necessary for transcriptional regulation by Runx and SMAD proteins (12, 37) . A previous study also reported a similar coordinated action of SMAD and Runx3 drives the transcription of the GL␥2b gene in response to TGF␤1 stimulation (24) .
With respect to the functional role of Runx3 in the expression of the ATRAP gene, the results of the RBE-decoy transfection experiment and Runx siRNA-mediated endogenous Runx knockdown assay indicate that it is Runx3 among the Runx family transcription factors that is critically involved in the activation of ATRAP gene expression. Interestingly, multiple RBEs are present throughout the mouse ATRAP locus, including both the coding and noncoding regions (data not shown). A previous study showed that Runx2 directly regulated ribosomal biogenesis through multiple RBEs in the ribosomal RNA locus by DNA binding and indirectly by affecting chromatin histone modification (36) . The results of the present study indicate that the direct DNA binding of Runx3 to RBE is involved in the activation of ATRAP gene expression in mDCT cells, but further studies are needed to elucidate the molecular mechanism of Runx3-mediated transcriptional activation of the ATRAP gene promoter.
The Runx3 gene is reported to be expressed in the mesenchymal elements; it controls the proper development of gastric endothelial cells by apoptosis and also acts as a tumor suppressor gene (5) . In this study, we showed that in vitro Runx3 as well as ATRAP is expressed in mDCT cells and, in vivo, in the distal tubules of the mouse kidney. To the best of our knowledge, this is the first report demonstrating that Runx3 is expressed in renal tubular cells. Furthermore, the intrarenal localization of Runx3 does not completely coincide with that of ATRAP in terms of the tubular segments. While the expression of the Runx3 protein was mainly localized in the DCT and CNT of the distal tubules, the ATRAP protein was widely distributed along the renal tubules (3, 29) .
Our previous studies showed that the intracellular localization of ATRAP also does not completely coincide with that of the AT1 receptor, the binding partner of ATRAP, in the tubular segments (29) . The results of in vitro experiments showed that ANG II treatment induces substantial colocalization of ATRAP and AT1 receptor in cardiovascular cells (1, 28) , thereby suggesting that ATRAP and the AT1 receptor can have other effectors, as reported (10) . Therefore, the results of the present study suggest that there are other factor(s), such as coactivator(s), which cooperate with both Runx3 and ATRAP. Further molecular screens for both Runx3 and ATRAP are needed to identify such putative additional partners for these molecules, which may act cooperatively or independently in terms of timing and specific cellular locations in the kidney.
Finally, UUO is a well-established experimental model of progressive tubulointerstitial fibrosis. UUO leads to changes in renal hemodynamics, inflammatory responses in the kidney, and tubular hypertrophy and interstitial fibrosis of the affected kidney (23) . The renin-angiotensin system is also known to be activated in UUO, and the results of the present study showed a significant downregulation of Runx3 and ATRAP expression in the affected kidney, suggesting a possible role of Runx3 in the regulation of ATRAP in vivo.
The limitations of the present study include the lack of data on the effect of serum starvation on ATRAP binding to the AT1 receptor and its subsequent internalization. Further studies are needed to elucidate the function of ATRAP on AT1 receptor signaling under starvation conditions, and these will be taken up in due course. Caution should be used in interpreting the finding of this study in terms of the pathophysiology in humans, and further studies are warranted to investigate the role of Runx3 in ATRAP regulation under various physiological and/or pathological conditions. In summary, the results of the present study demonstrate the Runx3-mediated basal transcriptional activation of ATRAP gene in renal distal tubular cells is dependent on its DNA binding. Furthermore, the results of immunohistochemical analysis show a partial colocalization of Runx3 and ATRAP proteins in the distal tubules of the mouse kidney. These findings suggest an interesting molecular link between Runx3, one of the important Runt-related transcription factors in the determination of cell lineage and differentiation (35) , and ATRAP, a newly emerging component of the renin-angiotensin system, a link that is likely to play a role in the regulation of ATRAP gene expression in the renal distal tubules.
